These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
686 related articles for article (PubMed ID: 19434490)
21. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
22. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214 [TBL] [Abstract][Full Text] [Related]
23. Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells. Abukhdeir AM; Blair BG; Brenner K; Karakas B; Konishi H; Lim J; Sahasranaman V; Huang Y; Keen J; Davidson N; Vitolo MI; Bachman KE; Park BH Breast Cancer Res Treat; 2006 Sep; 99(1):23-33. PubMed ID: 16541319 [TBL] [Abstract][Full Text] [Related]
24. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Frasor J; Chang EC; Komm B; Lin CY; Vega VB; Liu ET; Miller LD; Smeds J; Bergh J; Katzenellenbogen BS Cancer Res; 2006 Jul; 66(14):7334-40. PubMed ID: 16849584 [TBL] [Abstract][Full Text] [Related]
25. Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen. Levy N; Paruthiyil S; Zhao X; Vivar OI; Saunier EF; Griffin C; Tagliaferri M; Cohen I; Speed TP; Leitman DC Mol Cell Endocrinol; 2010 Feb; 315(1-2):201-7. PubMed ID: 19744542 [TBL] [Abstract][Full Text] [Related]
26. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk. Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631 [TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070 [TBL] [Abstract][Full Text] [Related]
28. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1. Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420 [TBL] [Abstract][Full Text] [Related]
29. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related]
30. Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells. Bolanz KA; Kovacs GG; Landowski CP; Hediger MA Mol Cancer Res; 2009 Dec; 7(12):2000-10. PubMed ID: 19996302 [TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111 [TBL] [Abstract][Full Text] [Related]
32. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Lee SO; Nadiminty N; Wu XX; Lou W; Dong Y; Ip C; Onate SA; Gao AC Cancer Res; 2005 Apr; 65(8):3487-92. PubMed ID: 15833885 [TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands. Stope MB; Popp SL; Knabbe C; Buck MB Breast Cancer Res Treat; 2010 Apr; 120(2):357-67. PubMed ID: 19370415 [TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines. Lattrich C; Stegerer A; Häring J; Schüler S; Ortmann O; Treeck O Steroids; 2013 Feb; 78(2):195-202. PubMed ID: 23153457 [TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of ERβ on proliferation, invasion, and tumor formation of MCF-7 breast cancer cells--prognostication for the use of ERβ-selective therapy. Li H; Tu Z; An L; Qian Z; Achilefu S; Gu Y Pharm Biol; 2012 Jul; 50(7):839-49. PubMed ID: 22486657 [TBL] [Abstract][Full Text] [Related]
37. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha. Gougelet A; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088 [TBL] [Abstract][Full Text] [Related]
38. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038 [TBL] [Abstract][Full Text] [Related]
39. Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells. Behrens D; Gill JH; Fichtner I Mol Cell Endocrinol; 2007 Aug; 274(1-2):19-29. PubMed ID: 17597290 [TBL] [Abstract][Full Text] [Related]
40. Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. Faouzi M; Hague F; Potier M; Ahidouch A; Sevestre H; Ouadid-Ahidouch H J Cell Physiol; 2011 Feb; 226(2):542-51. PubMed ID: 20683915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]